Blood filter trial for long COVID pulled before start
NCT ID NCT06637800
First seen Apr 30, 2026 · Last updated Apr 30, 2026
Summary
This study planned to test a blood-filtering device called Seraph 100 in 100 adults with Long COVID. Participants would receive two treatments on consecutive days and be checked after 3 days and 4 weeks. However, the trial was withdrawn before any patients enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Angeles Tijuana
Tijuana, Mexico
Conditions
Explore the condition pages connected to this study.